Patient Preference and Adherence
Volume 11, 2017 - Issue
Open access
60
Views
10
CrossRef citations to date
0
Altmetric
Original Research
Adherence to tobramycin inhaled powder vs inhaled solution in patients with cystic fibrosis: analysis of US insurance claims data
Kamal Hamed1 Novartis Pharmaceuticals Corporation, East Hanover, NJ, USACorrespondence[email protected]
, Valentino Conti2 Novartis Global Service Center, Dublin, Ireland
, Hengfeng Tian1 Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA
& Emil Loefroth3 Novartis Sverige AB, Täby, Sweden
Pages 831-838
|
Published online: 27 Apr 2017
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.